E-LIB Suche - Ergebnisse für: Rubens, Robert

1

Safety and efficacy of TAK-925 in adults with obstructive s..:

Rubens, Robert ; Olsson, Tina ; Neuwirth, Rachel...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

2

Opt‐Out Design for an Observational Toxicology Study Involv..:

Calle, Paul ; Blanckaert, Peter ; Lemoyne, Sabine.
Ethics & Human Research. 43 (2021) 5 - p. 36-41 , 2021

Link: https://doi.org/10.1002/..

3

Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203..:

Modi, Nishit B. ; Mittur, Aravind ; Rubens, Robert..
Clinical Neuropharmacology. 42 (2019) 1 - p. 4-8 , 2019

Link: https://doi.org/10.1097/..

4

Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkins..:

Modi, Nishit B. ; Mittur, Aravind ; Dinh, Phillip..
Clinical Neuropharmacology. 42 (2019) 5 - p. 149-156 , 2019

Link: https://doi.org/10.1097/..

5

DT‐02‐02: TOMMORROW: RESULTS FROM A PHASE 3 TRIAL TO DELAY ..:

Alexander, Robert ; Burns, Daniel K. ; Welsh-Bohmer, Kathleen A....
Alzheimer's & Dementia. 15 (2019) 7S_Part_28 - p. , 2019

Link: https://doi.org/10.1016/..

6

Dosing Patterns during Conversion to IPX066, Extended-Relea..:

Morgan, John C. ; Dhall, Rohit ; Rubens, Robert..
Parkinson's Disease. 2018 (2018) - p. 1-8 , 2018

Link: https://doi.org/10.1155/..

7

Effect of Concomitant Medications on the Safety and Efficac..:

LeWitt, Peter A. ; Verhagen Metman, Leo ; Rubens, Robert...
Clinical Neuropharmacology. 41 (2018) 2 - p. 47-55 , 2018

Link: https://doi.org/10.1097/..

8

Conversion to carbidopa and levodopa extended-release (IPX0..:

Tetrud, James ; Nausieda, Paul ; Kreitzman, David...
Journal of the Neurological Sciences. 373 (2017) - p. 116-123 , 2017

Link: https://doi.org/10.1016/..

9

Efficacy of Zolmitriptan Nasal Spray for the Treatment of A..:

Winner, Paul ; Rubens, Robert ; Rustay, Nathan..
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

10

Dosing and efficacy of extended-release carbidopa-levodopa ..:

Gupta, Suneel ; Khanna, Sarita ; Kell, Sherron.
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

11

Improvements in activities of daily living and quality of l..:

Dhall, Rohit ; Gil, Ramon ; Lindemulder, Elizabeth..
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

12

Efficacy of IPX066, Extended-Release Carbidopa-Levodopa: Su..:

Dhall, Rohit ; Struck, Lynn ; Rubens, Robert..
Neurology. 86 (2016) 16_supplement - p. , 2016

Link: https://doi.org/10.1212/..

13

Dosing Patterns During Conversion to IPX066, Extended-Relea..:

Morgan, John ; Stacy, Mark ; Rubens, Robert..
Neurology. 86 (2016) 16_supplement - p. , 2016

Link: https://doi.org/10.1212/..

14

Onset and duration of motor effects with IPX066, levodopa-c..:

Gupta, Suneel ; Khanna, Sarita ; Rubens, Robert.
Parkinsonism & Related Disorders. 22 (2016) - p. e93 , 2016

Link: https://doi.org/10.1016/..

15

Onset and duration of motor effects with IPX066, levodopa-c..:

Gupta, Suneel ; Khanna, Sarita ; Rubens, Robert.
Parkinsonism & Related Disorders. 22 (2016) - p. e16 , 2016

Link: https://doi.org/10.1016/..